KV Pharmaceutical and ETHEX Recall News |
|
We have compiled the latest news on drugs subject to recall by KV Pharmaceutical and ETHEX Corporation due to manufacturing defects. If you or a loved one has been injured by one of these defective drugs and you would like more information on litigation against the manufacturer, please contact us. |
|
KV Pharmaceutical Dives After Halting Drug Shipments |
|
 |
Bloomberg | December 23, 2008 |
| KV Pharmaceutical Co. lost half its value in New York trading after the drugmaker, announcing a third recall of medicines that may contain excess doses, stopped shipping prescription tablets. | |
KV Pharmaceutical CEO Leaves on Uncertain Terms |
|
 Marc Hermelin Former CEO, KV Pharmaceutical Co. |
Associated Press | December 5, 2008 |
The chief executive of drugmaker KV Pharmaceutical Co. is leaving under disputed circumstances, as Marc Hermelin says he informed the company of his retirement Monday, while KV asserts it fired Hermelin on Friday. In a statement Friday morning, Hermelin said he notified the company Dec. 1 that he was retiring as chairman and CEO. He said he retained the recruitment firm Bench International on Nov. 24 to help KV find a successor. A family spokesman says Hermelin ceased to be an employee Monday. |
|
Voluntary Recall of Potentially Oversized Tablets Expanded |
|
|
MedPage Today| November 10, 2008 |
ETHEX Corporation announced the voluntary recall of lots of five generic medications because they may contain more than the labeled amount of active ingredient, the FDA said. The recall applies to 150-, 225-, and 300-mg propafenone HCl tablets, 30- and 60-mg isosorbide mononitrate extended-release tablets, 15-mg morphine sulfate extended-release tablets, 15- and 30-mg morphine sulfate immediate-release tablets, and 10-mg dextroamphetamine sulfate tablets. |
|
ETHEX Corporation Voluntarily Recalls Three Lots of Dextroamphetamine Sulfate 5mg Tablets Due to the Potential for Oversized Tablets |
|
 |
FDA | October 15, 2008 |
ETHEX Corporation announced today that it has voluntarily recalled three specific lots (77946, 81141 and 81142) of Dextroamphetamine Sulfate 5 mg tablets, as a precaution, due to the possible presence of oversized tablets. Oversized tablets may contain as much as about twice the labeled amount of the active ingredient. The recalled lots were distributed by ETHEX Corporation under an "ETHEX" label between January 2007 and May 2008. The 5 mg product is an orange round tablet debossed with "ETHEX" and "311" on one side. |
|
Contact Us |
Your Legal Rights |
If you have been harmed by a drug recalled by ETHEX Corporation, you may be entitled to compensation. You should act immediately to contact a lawyer experienced in matters involving defective pharmaceuticals. |